Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Solid Tumor × lenvatinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 99 Cholangiocarcinoma 22 Carcinoma, Renal Cell 16 Liver Neoplasms 10 Biliary Tract Neoplasms 9 Stomach Neoplasms 8 Endometrial Neoplasms 7 Breast Neoplasms 7 Thyroid Neoplasms 6 Neoplasms 6 Recurrence 5 Uterine Cervical Neoplasms 4 Melanoma 4 Thyroid Cancer, Papillary 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Adenocarcinoma 3 Uveal Melanoma 2 Thyroid Carcinoma, Anaplastic 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Paraganglioma, Extra-Adrenal 2 Mesothelioma, Malignant 2 Liver Diseases 2 Kidney Neoplasms 2

Interventions

toripalimab 5 tislelizumab 3 spartalizumab 2 pembrolizumab 2 camrelizumab 2 Injections 2 Immune Checkpoint Inhibitors 2 Drug Therapy 2 sintilimab 1 penpulimab 1 olaparib 1 lenvatinib 1 fludarabine 1 conteltinib 1 atezolizumab 1 anlotinib 1 adagrasib 1 Sorafenib 1 Sirolimus 1 Paclitaxel 1 Oxaliplatin 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Irinotecan 1 Inosine 1 Immunotherapy 1 Gemcitabine 1 Fluorouracil 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06081907 2024-05-30

Promise

Hunan Province Tumor Hospital

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡